173 related articles for article (PubMed ID: 19880024)
1. Botulinum toxin A prolongs functional durability of voice prostheses in laryngectomees with pharyngoesophageal spasm.
Krause E; Hempel JM; Gürkov R
Am J Otolaryngol; 2009; 30(6):371-5. PubMed ID: 19880024
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injection to improve tracheoesophageal speech after total laryngectomy.
Zormeier MM; Meleca RJ; Simpson ML; Dworkin JP; Klein R; Gross M; Mathog RH
Otolaryngol Head Neck Surg; 1999 Mar; 120(3):314-9. PubMed ID: 10064631
[TBL] [Abstract][Full Text] [Related]
3. Use of botulinum toxin in voice restoration after laryngectomy.
Khemani S; Govender R; Arora A; O'Flynn PE; Vaz FM
J Laryngol Otol; 2009 Dec; 123(12):1308-13. PubMed ID: 19607736
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injection for failed tracheo-oesophageal voice in laryngectomees: the Sunderland experience.
Ramachandran K; Arunachalam PS; Hurren A; Marsh RL; Samuel PR
J Laryngol Otol; 2003 Jul; 117(7):544-8. PubMed ID: 12901809
[TBL] [Abstract][Full Text] [Related]
5. Management of pharyngoesophageal spasm with Botox.
Chao SS; Graham SM; Hoffman HT
Otolaryngol Clin North Am; 2004 Jun; 37(3):559-66. PubMed ID: 15163601
[TBL] [Abstract][Full Text] [Related]
6. Operative prevention and management of voice-limiting pharyngoesophageal spasm.
Bayles SW; Deschler DG
Otolaryngol Clin North Am; 2004 Jun; 37(3):547-58. PubMed ID: 15163600
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin for pharyngeal constrictor muscle spasm in tracheoesophageal voice restoration.
Hamaker RC; Blom ED
Laryngoscope; 2003 Sep; 113(9):1479-82. PubMed ID: 12972919
[TBL] [Abstract][Full Text] [Related]
8. Does diagnostic lignocaine block have a therapeutic value in treatment of hypertonic pharyngoesophageal segment?
Desphande M; Rao V; Chaukar D; Chaturvedi P; Pai P; D'cruz A
Laryngoscope; 2008 Jul; 118(7):1324-5. PubMed ID: 18438264
[No Abstract] [Full Text] [Related]
9. Videostroboscopy of the pharyngoesophageal segment in laryngectomy patients treated with botulinum toxin.
Meleca RJ; Dworkin JP; Zormeier MM; Simpson ML; Shibuya T; Mathog RH
Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):38-43. PubMed ID: 10889479
[TBL] [Abstract][Full Text] [Related]
10. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
12. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin type A for chronic cough: a neuropathic model.
Chu MW; Lieser JD; Sinacori JT
Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):447-52. PubMed ID: 20479373
[TBL] [Abstract][Full Text] [Related]
16. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
18. Injection of botulinum toxin for the treatment of post-laryngectomy pharyngoesophageal spasm-related disorders.
Lightbody KA; Wilkie MD; Kinshuck AJ; Gilmartin E; Lewis-Jones H; Jones TM; Lancaster J
Ann R Coll Surg Engl; 2015 Oct; 97(7):508-12. PubMed ID: 26414361
[TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous chemical myotomy using botulium neurtoxin A under local anaesthesia in the treatment of cricopharyngeal dysphagia following laryngectomy.
Natt RS; McCormick MS; Clayton JM; Ryall C
Auris Nasus Larynx; 2010 Aug; 37(4):500-3. PubMed ID: 20036474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
